Skip to main content
SpringerLink
Log in

Eine Strahlentherapie des initialen Bulks verbessert nach abgeschlossener Immunchemotherapie das Outcome älterer Patienten mit aggressivem B-Zell-Lymphom

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Held G, Murawski N, Ziepert M et al (2014) Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. J Clin Oncol. doi:10.1200/JCO.2013.51.4505

  2. Ng AK, Bernardo MV, Weller E et al (2002) Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 100:1989–1996

    Article  CAS  PubMed  Google Scholar 

  3. Galper SL, Yu JB, Mauch PM et al (2011) Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood 117:412–418

    Article  CAS  PubMed  Google Scholar 

  4. Ng AK, Bernardo MP, Weller E et al (2002) Long-term survival and competing causes of death in patients with early-stage Hodgkin’s disease treated at age 50 or younger. J Clin Oncol 20:2101–2108

    Article  PubMed  Google Scholar 

  5. Miller TP, Dahlberg S, Cassady JR et al (1998) Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin’s lymphoma. N Engl J Med 339:21–26

    Article  CAS  PubMed  Google Scholar 

  6. Miller T, Leblanc M, Spier C et al (2001) CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin’s lymphomas: Update of the Southwest Oncology Group (SWOG) randomized trial. Blood 98:724a

    Article  Google Scholar 

  7. Coiffier B, Thieblemont C, Van Den Neste E et al (2010) Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d’Etudes des Lymphomes de l’Adulte. Blood 16:2040–2045

    Article  Google Scholar 

  8. Pfreundschuh M, Schubert J, Ziepert M et al (2008) Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20_B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 9:105–116

    Article  CAS  PubMed  Google Scholar 

  9. Juweid ME, Wiseman GA, Vose JM et al (2005) Response assessment of aggressive non-Hodgkin’s lymphoma by integrated International Workshop Criteria and flouorine-18–fluorodeoxyglucose positron emission tomography. J Clin Oncol 23:4652–4661

    Article  PubMed  Google Scholar 

  10. Sehn LH, Savage KJ, Hoskins P (2011) Treatment of limited-stage DLBCL can be effectively tailored using a PET-based approach. Ann Oncol 22(suppl 4; abstr 28)

  11. Swerdlow AJ, Barber JA, Hudson GV et al (2000) Risk of second malignancy after Hodgkin’s disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 18:498–509

    CAS  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt

S. Kubicka gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Medizinische Klinik I, Kreisklinik Reutlingen, Steinenbergstr. 31, 72764, Reutlingen, Deutschland

    Stefan Kubicka

Authors
  1. Stefan Kubicka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Kubicka.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kubicka, S. Eine Strahlentherapie des initialen Bulks verbessert nach abgeschlossener Immunchemotherapie das Outcome älterer Patienten mit aggressivem B-Zell-Lymphom. Strahlenther Onkol 190, 770–771 (2014). https://doi.org/10.1007/s00066-014-0701-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-014-0701-6

Search

Navigation